market

Intermap Announces Date for Second Quarter Earnings

Company will announce second quarter 2025 financial results and host a conference call on August 14, 2025 August 08, 2025…

6 days ago

Xauras Launches with Strong Global Momentum, Positioning Itself as a Game-Changer in the $100B DeFi Lending Market

London, UK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- August 2025 | Global – In a significant move that’s drawing attention…

7 days ago

Folqs Highlights First-Day, Grass-Fed Colostrum Powder Amid Global Surge in Demand

Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Folqs, a U.S.-based wellness company, introduces new consumer product, Folqs First-Day Colostrum…

1 week ago

Apex Invest Digital Selects Coinbase Asset Management as Headline Sponsor for Inaugural Apex Invest Digital Program

NEW YORK, Aug. 7, 2025 /PRNewswire/ --  Apex Invest is pleased to announce Coinbase Asset Management as Headline Sponsor for…

1 week ago

izmostock Unveils All-New Global Portal

The World's Largest Automotive Image Repository Gets a Powerful New Platform in a $10 Billion Market BANGALORE, India, Aug. 8,…

1 week ago

DERMALOG JENETRIC Introduces Mobile Palm Scanner LIVETOUCH PALM to the U.S. Market

At the 2025 IAI Conference in Orlando, DERMALOG JENETRIC will debut the ultra-compact LIVETOUCH PALM. Combining mobility, durability and intuitive…

1 week ago

Artmarket.com: Double-digit growth in Q2 2025, Revolutionary Artprice-Perplexity AI rapprochement: The Mixed Subscription for the Second Half of 2025/2026 Will Redefine the Intelligence of the Art Market

PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding President, and the employees of Artprice are mobilizing…

1 week ago

Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition of UDENYCA

AHMEDABAD, India, Aug. 6, 2025 /PRNewswire/ -- Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has…

1 week ago

Intas Pharmaceuticals Launches HETRONIFLY (Serplulimab), India’s First Novel Immunotherapy for Advanced Small Cell Lung Cancer

AHMEDABAD, India, Aug. 5, 2025 /PRNewswire/ -- Intas Pharmaceuticals has launched HETRONIFLY™ (Serplulimab), the first PD-1 inhibitor globally approved for…

1 week ago

Bullet Blockchain Announces Strategic Initiatives to Accelerate Growth and Cement Market Leadership

LAS VEGAS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Bullet Blockchain, Inc. (OTC: BULT) (“Bullet Blockchain” or the “Company”), the only…

2 weeks ago